Health Care

Amgen to buy Horizon Therapeutics for $26.4B

Amgen Inc. announced on Monday that it will acquire Horizon Therapeutics for $26 billion to further grow the company’s medical legacy. Horizon's best-selling drug is Tepezza.

How is pharmacist burnout being addressed?

There’s a growing trend of pharmacists being overworked, and this has been exacerbated within the last three years, even prior to the coronavirus pandemic.